Literature DB >> 20611033

Are HIV-positive persons progressing faster after diagnosis over the epidemic?

Nancy F Crum-Cianflone, Qian Ren, Lynn E Eberly, Anuradha Ganesan, Amy Weintrob, Vincent Marconi, Robert V Barthel, Brian K Agan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20611033      PMCID： PMC2901894          DOI： 10.1097/QAI.0b013e3181e2d6c1

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.

Authors:  P Vanhems; J Lambert; M Guerra; B Hirschel; R Allard
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

2.  Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.

Authors:  Amy C Weintrob; Ann M Fieberg; Brian K Agan; Anuradha Ganesan; Nancy F Crum-Cianflone; Vincent C Marconi; Mollie Roediger; Susan L Fraser; Scott A Wegner; Glenn W Wortmann
Journal:  J Acquir Immune Defic Syndr       Date:  2008-09-01       Impact factor: 3.731

3.  Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

Authors:  Nancy Crum-Cianflone; Lynn Eberly; Yafeng Zhang; Anuradha Ganesan; Amy Weintrob; Vincent Marconi; R Vincent Barthel; Susan Fraser; Brian K Agan; Scott Wegner
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

4.  Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002.

Authors:  Maria Dorrucci; Giovanni Rezza; Kholoud Porter; Andrew Phillips
Journal:  J Infect Dis       Date:  2007-01-10       Impact factor: 5.226
  4 in total
  4 in total

1.  Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Authors:  Joshua T Herbeck; Viktor Müller; Brandon S Maust; Bruno Ledergerber; Carlo Torti; Simona Di Giambenedetto; Luuk Gras; Huldrych F Günthard; Lisa P Jacobson; James I Mullins; Geoffrey S Gottlieb
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

2.  Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.

Authors:  Shigeru Nomura; Noriaki Hosoya; Zabrina L Brumme; Mark A Brockman; Tadashi Kikuchi; Michiko Koga; Hitomi Nakamura; Tomohiko Koibuchi; Takeshi Fujii; Jonathan M Carlson; David Heckerman; Ai Kawana-Tachikawa; Aikichi Iwamoto; Toshiyuki Miura
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

3.  Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection.

Authors:  Sara Lodi; Martin Fisher; Andrew Phillips; Andrea De Luca; Jade Ghosn; Ruslan Malyuta; Robert Zangerle; Santiago Moreno; Philippe Vanhems; Faroudy Boufassa; Marguerite Guiguet; Kholoud Porter
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

4.  Relational concurrency, stages of infection, and the evolution of HIV set point viral load.

Authors:  Steven M Goodreau; Sarah E Stansfield; James T Murphy; Kathryn C Peebles; Geoffrey S Gottlieb; Neil F Abernethy; Joshua T Herbeck; John E Mittler
Journal:  Virus Evol       Date:  2018-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.